Table 1
TRUVADA | KIVEXA | |||||||
|---|---|---|---|---|---|---|---|---|
All (mean 122,106) | VL >100,000 (mean 263,684) | VL 10–100,000 (mean 45, 772) | VL <10,000 (mean 5243) | All (mean 99,883) | VL > 100,000 (mean 256,364) | VL 10–100,000 (mean 48, 221) | VL < 10,000 (mean 6214) | |
Number of patients | 53 | 20 | 23 | 10 | 33 | 9 | 20 | 4 |
VL <50 at 3 months (%) | 60 | 35 | 74 | 80 | 73 | 60 | 80 | 75 |
Vl < 50 at 4 months (%) | 75 | 60 | 87 | 90 | 79 | 78 | 85 | 75 |
VL < 50 at 6 months (%) | 83 | 80 | 91 | 90 | 91 | 89 | 90 | 100 |
VL < 1000 at 4 weeks (%) | 67 | 45 | 83 | 70 | 70 | 22 | 85 | 100 |